Strength Seen in Corcept Therapeutics (CORT): Stock Soars 10.8%

Dec 22, 2017 · Corcept Therapeutics (CORT) was a big mover last session, as the company saw its shares rise more than 10% on the day amid huge volumes.

8%
OFF

Strength Seen In Corcept Therapeutics (CORT): Stock Soars 10.8%

2 weeks from now

Dec 22, 2017 · Corcept Therapeutics (CORT) was a big mover last session, as the company saw its shares rise more than 10% on the day amid huge volumes.

yahoo.com

8%
OFF

Strength Seen In Corcept Therapeutics (CORT): Stock Soars 10.8%

2 weeks from now

Dec 21, 2017 · Stocks Analysis by Zacks Investment Research covering: Corcept Therapeutics Incorporated, Sucampo Pharmaceuticals Inc. Read Zacks Investment Research's latest article …

investing.com

5%
OFF

Strength Seen In Corcept (CORT): Can Its 5.5% Jump Turn Into …

2 weeks from now

Oct 21, 2024 · Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands …

yahoo.com

$61.67
OFF

Corcept Therapeutics Stock Soars To All-time High Of $61.67

2 weeks from now

Dec 4, 2024 · Corcept Therapeutics (NASDAQ: CORT) Inc. has reached an unprecedented milestone as its stock price soared to an all-time high of $61.67, marking a significant moment …

investing.com

5%
OFF

Strength Seen In Corcept (CORT): Can Its 5.5% Jump Turn Into

2 weeks from now

Oct 21, 2024 · Corcept Therapeutics (CORT) shares soared 5.5% in the last trading session to close at $49.75. The move was backed by solid volume with far more shares changing hands …

nasdaq.com

1%
OFF

Corcept Therapeutics Incorporated (CORT) Soars To 52-Week …

2 weeks from now

Nov 5, 2024 · Have you been paying attention to shares of Corcept Therapeutics (CORT)?Shares have been on the move with the stock up 12.1% over the past month. The stock hit a new 52 …

yahoo.com

98%
OFF

Corcept Therapeutics Incorporated (CORT) Soars To 52-Week High …

2 weeks from now

Nov 5, 2024 · For the current fiscal year, Corcept is expected to post earnings of $1.25 per share on $683.78 million in revenues. This represents a 32.98% change in EPS on a 41.75% …

nasdaq.com

8%
OFF

Strength Seen In Corcept Therapeutics (CORT): Stock Soars 10.8%

2 weeks from now

Dec 22, 2017 · Corcept Therapeutics (CORT) was a big mover last session, as the company saw its shares rise more than 10% on the day amid huge volumes. Strength Seen in Corcept …

zacks.com

5%
OFF

Strength Seen In Corcept (CORT): Can Its 5.5% Jump Turn Into …

2 weeks from now

Oct 21, 2024 · Corcept Therapeutics (CORT Quick Quote CORT - Free Report) shares soared 5.5% in the last trading session to close at $49.75.The move was backed by solid volume with …

zacks.com

50%
OFF

Burney Co. Raises Stock Position In Corcept Therapeutics

2 weeks from now

1 day ago · Over the last ninety days, insiders sold 38,011 shares of company stock worth $1,951,268. Insiders own 20.50% of the company's stock. Corcept Therapeutics Stock Up 2.3 …

marketbeat.com

$111188
OFF

Corcept Therapeutics Director Daniel Swisher Sells $111,188 In Stock

2 weeks from now

1 day ago · Corcept Therapeutics (NASDAQ:CORT), based in Redwood (NYSE:RWT) City, California, is known for its work in pharmaceutical preparations, and Swisher's transactions …

investing.com

$693262
OFF

NJ's Wealthiest Counties Include Morris, Bergen, Hunterdon, More

2 weeks from now

Nov 29, 2024 · The median home value there peaks at $693,262 — the highest in the top four — and investment income soars to $88,757, but its lower median income keeps it fourth in New …

northjersey.com

FAQs about Strength Seen in Corcept Therapeutics (CORT): Stock Soars 10.8% Coupon?

How did Corcept Therapeutics incorporated (Cort) stock perform in 2025?

The one-month return of Corcept Therapeutics Incorporated (NASDAQ:CORT) was -12.16%, and its shares gained 105.82% of their value over the last 52 weeks. On January 6, 2025, Corcept Therapeutics Incorporated (NASDAQ:CORT) stock closed at $51.66 per share with a market capitalization of $5.413 billion. ...

Should you buy Corcept Therapeutics (Cort)?

Corcept Therapeutics (CORT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. The Zacks rating relies solely on a company's changing earnings picture. ...

Will Corcept (Cort) move higher on growing optimism about earnings prospects?

Corcept (CORT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). ...

What does the Zacks rating upgrade mean for Corcept (Corcept)?

As such, the Zacks rating upgrade for Corcept is essentially a positive comment on its earnings outlook that could have a favorable impact on its stock price. The change in a company's future earnings potential, as reflected in earnings estimate revisions, has proven to be strongly correlated with the near-term price movement of its stock. ...

Should you buy Corcept (Corcept) based on rising earnings estimates?

Fundamentally speaking, rising earnings estimates and the consequent rating upgrade for Corcept imply an improvement in the company's underlying business. Investors should show their appreciation for this improving business trend by pushing the stock higher. ...

What does CORT Certified promise?

All the furniture we sell is backed by the CORT Certified promise, our commitment to provide trustworthy service and quality furnishings to you and yours. Most cheap furniture stores can’t offer that kind of commitment. ...